Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeffrey H. Kozlow is active.

Publication


Featured researches published by Jeffrey H. Kozlow.


Annals of Plastic Surgery | 2016

Autologous Fat Grafting After Breast Reconstruction in Postmastectomy Patients: Complications, Biopsy Rates, and Locoregional Cancer Recurrence Rates.

Christodoulos Kaoutzanis; Minqiang Xin; Tiffany N.S. Ballard; Kathleen B. Welch; Adeyiza O. Momoh; Jeffrey H. Kozlow; David L. Brown; Paul S. Cederna; Edwin G. Wilkins

BackgroundAutologous fat grafting is widely used for refinements in postmastectomy breast reconstruction. However, there are few studies evaluating outcomes in this patient population. The purpose of this study was to assess outcomes of autologous fat grafting after breast reconstruction in postmastectomy patients. MethodsWe retrospectively reviewed the records of consecutive postmastectomy patients who underwent autologous fat grafting after breast reconstruction at a university center over a 5-year period. Patients with at least 6 months of follow-up were included. Medical records were reviewed for demographics, operative details, complications, incidence of palpable masses, and/or suspicious breast imaging findings requiring biopsy, and locoregional cancer recurrence. Descriptive statistics were generated. ResultsBetween January 2008 and July 2013, 108 women and a total of 167 breast reconstructions underwent autologous fat grafting for revision of postmastectomy breast reconstruction. Their ages ranged from 22 to 71 years (mean, 48 years). Fat grafts were harvested, processed, and injected using the Coleman technique. The mean number of fat grafting procedures was 1.3 (range, 1–4) per breast. Follow-up ranged from 6 to 57 months (mean, 20.2 months). Fifty-three (31.7%) breasts underwent imaging after autologous fat grafting. Suspicious imaging findings requiring biopsy were discovered in 4 (2.4%) breasts, and clinically palpable lesions combined with suspicious imaging findings requiring biopsy were present in another 4 (2.4%) breasts. All 8 biopsies showed fat necrosis, scar, or oil cysts without evidence of malignancy. One (0.6%) local complication (a wound infection at the recipient site requiring oral antibiotics) after autologous fat grafting was reported. During the limited follow-up period, there were no locoregional cancer recurrences. ConclusionsAutologous fat grafting in conjunction with breast reconstruction resulted in a biopsy rate of 4.8%, and no cases of locoregional cancer recurrence were observed. Based on these preliminary findings, autologous fat grafting appears to be a relatively safe procedure for refinement of the reconstructed breast in postmastectomy patients.


Hand Clinics | 2011

Current concepts in the surgical management of rheumatoid and osteoarthritic hands and wrists

Jeffrey H. Kozlow; Kevin C. Chung

Rheumatoid arthritis (RA) is a progressively destructive disease. Gradual loss of hand function in RA patients affects their ability for self-care and interferes with their productivity in society. The continuing improvement in the medical management of RA has markedly decreased the incidence of RA hand surgery. In contrast to RA, osteoarthritis (OA) has less inflammatory reaction in the joints and is characterized by degradation of cartilage, resulting in joint destruction and osteophyte formation. The initial treatment of OA is medication and therapy. Steroid injection into affected joints can provide short-term relief, though repeat injections carry a cumulative risk of weakening the soft tissue. In this article the authors share their extensive experience in RA and OA hand surgery to provide a clear discussion of the indications and outcomes of its practice.


Plastic and Reconstructive Surgery | 2016

Ibuprofen May Not Increase Bleeding Risk in Plastic Surgery: A Systematic Review and Meta-Analysis.

Brian P. Kelley; Katelyn G. Bennett; Kevin C. Chung; Jeffrey H. Kozlow

Background: Nonsteroidal antiinflammatory drugs such as ibuprofen are common medications with multiple useful effects, including pain relief and reduction of inflammation. However, surgeons commonly withhold all nonsteroidal antiinflammatory drugs perioperatively because of bleeding concerns. However, not all nonsteroidal antiinflammatory drugs irreversibly block platelet function. The authors hypothesized that the use of ibuprofen would have no effect on postoperative bleeding in plastic surgery patients. Methods: A literature review was performed using MEDLINE (PubMed), EMBASE, and the Cochrane Collaboration Library for primary research articles on ibuprofen and bleeding. Inclusion criteria were primary journal articles examining treatment of acute postoperative pain based on any modality. Data related to pain assessment, postoperative recovery, and complications were extracted. Bias assessment and meta-analysis were performed. Results: A total of 881 publications were reviewed. Four primary randomized controlled trials were selected for full analysis. Articles were of high quality by bias assessment. No significant difference was noted regarding bleeding events (p = 0.32), and pain control was noted to be equivalent. Conclusions: Ibuprofen is a useful medication in the setting of surgery, with multiple beneficial effects. This meta-analysis represents a small set of high-quality studies suggesting that ibuprofen provides pain control equivalent to narcotics. Importantly, ibuprofen was not associated with an increased risk of bleeding. Further large studies will be necessary to elucidate this issue further, but ibuprofen is a safe postoperative analgesic in patients undergoing common plastic surgery soft-tissue procedures. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.


Plastic and Reconstructive Surgery | 2015

Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy

Shailesh Agarwal; Kelley M. Kidwell; Casey T. Kraft; Jeffrey H. Kozlow; Michael S. Sabel; Kevin C. Chung; Adeyiza O. Momoh

Background: Recent studies suggest that the decisions to undergo breast reconstruction and contralateral prophylactic mastectomy are closely related. In this article, the relationship between method of reconstruction and decision to undergo contralateral prophylactic mastectomy is described. Recent trends in contralateral use in the context of literature questioning its oncologic benefit are also evaluated. Methods: Female patients with unilateral breast cancer were identified and data extracted from the Surveillance, Epidemiology, and End Results database from 2000 through 2010. Logistic regression analyses were performed to study the relationship between having contralateral prophylactic mastectomy and key demographic, oncologic, and reconstructive factors among women with unilateral breast cancer. Results: A total of 157,042 patients with unilateral breast cancer were included. The contralateral prophylactic mastectomy rate increased from 7.7 percent to 28.3 percent during the study period, and the proportion of reconstructed patients who underwent contralateral prophylactic mastectomy increased from 19 percent to 46 percent. Reconstruction was associated with higher odds of contralateral prophylactic mastectomy (OR, 2.79; 95 percent CI, 2.70 to 2.88; p < 0.0001). Among women who had reconstruction, implant-based reconstruction was associated with significantly higher odds of contralateral prophylactic mastectomy than autologous tissue reconstruction (OR, 1.38; p < 0.0001). Conclusions: This study confirms that reconstruction and the decision to undergo contralateral prophylactic mastectomy are closely related, with implant reconstruction dominating in these patients. Given the close relationship between reconstruction and the choice for contralateral prophylactic mastectomy, plastic surgeons should play an active role in educating patients to avoid decisions made based on inaccurate information. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.


JAMA Dermatology | 2013

Malignant Melanoma Arising in the Setting of Epidermolysis Bullosa Simplex: An Important Distinction From Epidermolysis Bullosa Nevus

Thomas L. Hocker; Matthew C. Fox; Jeffrey H. Kozlow; Joseph V. Gonzalez; Tor Shwayder; Lori Lowe; May P. Chan

IMPORTANCE Patients with epidermolysis bullosa (EB) do not carry a significantly increased risk of melanoma but are prone to developing large, markedly atypical melanocytic nevi (EB nevi), which may mimic melanoma clinically and histologically. Many authors now favor a conservative approach in managing atypical pigmented lesions in patients with EB. OBSERVATIONS We present the case of a 30-year-old woman with severe EB simplex who sought care for a large red and black ulcerated plaque. The clinical differential diagnosis included EB nevus and melanoma. An incisional punch biopsy specimen revealed an atypical melanocytic proliferation with focal florid pagetoid spread and involving elongated rete ridges, consistent with invasive acral lentiginous melanoma. The subsequent amputation was confirmatory. Micrometastasis was detected in 1 of 5 sentinel lymph nodes. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first reported case of melanoma arising in EB simplex-affected skin. It highlights the difficulty in differentiating melanoma from an EB nevus. Despite the increasing awareness of EB nevi, a high index of suspicion for melanoma should be maintained, and early biopsy is recommended when evaluating large pigmented lesions in patients with EB.


Plastic and Reconstructive Surgery | 2014

Comprehensive breast reconstruction in an academic surgical practice: an evaluation of the financial impact.

Ian C. Sando; Kevin C. Chung; Kelley M. Kidwell; Jeffrey H. Kozlow; Sunitha Malay; Adeyiza O. Momoh

Background: This study assessed the financial implications of providing all forms of breast reconstruction at a single academic institution with insurance as the primary mode of reimbursement. Methods: Billing records of 152 patients who underwent postmastectomy breast reconstruction offered at the University of Michigan for the 2012 fiscal year were reviewed. Professional and facility revenue, cost, and earnings for the first stage of reconstruction were calculated by applying actual collections and charges. Similar financial data were compiled for a subset of 49 patients who went on to complete reconstruction. Results: The professional revenue and expenses allocated to breast reconstruction were


Plastic and Reconstructive Surgery | 2014

Use of morphometric assessment of body composition to quantify risk of surgical-site infection in patients undergoing component separation ventral hernia repair.

Benjamin Levi; Peng Zhang; Jeffrey Lisiecki; Michael N. Terjimanian; Jacob Rinkinen; Shailesh Agarwal; Sven Holcombe; Jeffrey H. Kozlow; Stewart C. Wang; William M. Kuzon

647,437 and


Journal of The American Academy of Dermatology | 2018

Guidelines of care for the management of basal cell carcinoma

Christian L. Baum; Jeremy S. Bordeaux; Marc Brown; Klaus J. Busam; Daniel B. Eisen; Vivek Iyengar; Clifford W. Lober; David Margolis; Jane Messina; Alexander R. Miller; Stanley J. Miller; Eliot N. Mostow; Christen Mowad; Kishwer S. Nehal; Kristi Schmitt-Burr; Aleksandar Sekulic; Paul Storrs; Joyce Teng; Siegrid Yu; Conway C. Huang; Kevin Boyer; Wendy Smith Begolka; Murad Alam; John Y. S. Kim; Jeffrey H. Kozlow; Bharat Mittal; Jeffrey S. Moyer; Thomas Olencki; Phillip Rodgers

591,184, respectively (8.7 percent margin). Health care system facility revenue and costs were


Plastic and Reconstructive Surgery | 2017

Acellular Dermal Matrix in Immediate Expander/Implant Breast Reconstruction: A Multicenter Assessment of Risks and Benefits

M Sorkin; Ji Qi; Hyungjin Myra Kim; Jennifer B. Hamill; Jeffrey H. Kozlow; Andrea L. Pusic; Edwin G. Wilkins

2,762,797 and


Plastic and Reconstructive Surgery | 2015

The validity of hospital discharge data for autologous breast reconstruction research.

Jordan Talia; Shailesh Agarwal; Adeyiza O. Momoh; Edwin G. Wilkins; Jeffrey H. Kozlow

2,773,131, respectively (−0.4 percent margin). Physician reimbursement by surgical time was highest for delayed tissue expander placement (

Collaboration


Dive into the Jeffrey H. Kozlow's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge